Skip to product information
1 of 1

TLR7/8 agonist 13 [CAS 1402802-45-2]

TLR7/8 agonist 13 [CAS 1402802-45-2]

Size

SKU:QM-0014453

Price on request
Quantity

Request quote or documents

View full details
  • Description

    TLR7/8 agonist 13 is an orally active dual agonist of TLR7 (lowest effective concentrations (LEC) [hTLR7] = 1.6 μM) and TLR8 (LEC [hTLR8] = 1.6 μM) . TLR7/8 agonist 13 exhibits agonistic activity against human peripheral blood mononuclear cells (hPBMCs) (LEC [hPBMC] = 0.5 μM) . TLR7/8 agonist 13 induces endogenous IFNα, activating myeloid dendritic cells and monocytes toward a TH1 phenotype in mice and cynomolgus monkeys. TLR7/8 agonist 13 reduces viral load and HBV surface antigen expression in a mouse model of chronic AAV-HBV infection. TLR7/8 agonist 13 has the potential to indirectly induce IFNγ, which may promote HBV antigen-specific CD8 T cell-mediated responses. TLR7/8 agonist 13 can be used to study hepatitis B virus[1].

  • CAS Number

    [1402802-45-2]

  • Molecular Formula

    C12H22N4O2

  • Molecular Weight

    254.33

  • Smiles

    NC(N=C1N[C@H](CCO)CCCC)=NC=C1OC

  • Target

    HBV; IFNAR; Interleukin Related; Toll-like Receptor (TLR)

  • Isoform

    TLR7; TLR8

  • Shipping Conditions

    Room temperature

Your cart
Variant Variant total Quantity Price Variant total
1 EachQM-0014453
1 EachQM-0014453
£0.00/ea
£0.00
£0.00/ea £0.00

TLR7/8 agonist 13 [CAS 1402802-45-2]

TLR7/8 agonist 13 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.